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Loss of Nuclear Receptor SHP Impairs
but Does Not Eliminate Negative Feedback
Regulation of Bile Acid Synthesis
synthesis is triggered when the farnesoid X receptor
(FXR, NR1H4 ) binds excess bile acid and activates tran-
scription of a second nuclear receptor termed short het-
erodimer partner (SHP, NR0B2) (Goodwin et al., 2000;
Lu et al., 2000). SHP binds to and inhibits a third receptor,
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the CYP7A1 promoter binding factor (CPF, LRH, FTF, orUniversity of Texas Southwestern Medical Center
NR5A2), which normally activates genes encoding choles-Dallas, Texas 75390
terol 7-hydroxylase and sterol 12-hydroxylase (Castillo-2 Tularik Incorporated
Olivares and Gil, 2000; Lee and Moore, 2002; Nitta etSouth San Francisco, California 94080
al., 1999). Cholesterol 7-hydroxylase, encoded by the3 Deltagen Incorporated
Cyp7a1 gene, catalyzes the rate-limiting step in the ma-Redwood City, California 94063
jor synthetic pathway, and its inhibition leads to a drasti-
cally decreased output of bile acids. Sterol 12-hydroxy-
lase, the product of the Cyp8b1 gene, synthesizes cholicSummary
acid, a bile acid that binds to FXR and mediates suppres-
sion of Cyp7a1 (J. Li-Hawkins et al., submitted). TheThe in vivo role of the nuclear receptor SHP in feed-
decline in cholic acid ultimately restores Cyp7a1 expres-back regulation of bile acid synthesis was examined.
sion and returns the system to homeostasis. ActivationLoss of SHP in mice caused abnormal accumulation
of bile acid synthesis is mediated by the liver X receptorand increased synthesis of bile acids due to derepres-
 (LXR, NR1H3), a nuclear receptor that binds oxyste-sion of rate-limiting CYP7A1 and CYP8B1 hydroxylase
rols formed during the synthesis and metabolism of cho-enzymes in the biosynthetic pathway. Dietary bile
lesterol (Lu et al., 2001). In conjunction with CPF, LXRacids induced liver damage and restored feedback
stimulates transcription of Cyp7a1 (Chawla et al., 2001).regulation. A synthetic agonist of the nuclear receptor
Although the nuclear receptor pathway involving FXR,FXR was not hepatotoxic and had no regulatory ef-
SHP, CPF and LXR explains a majority of the knownfects. Reduction of the bile acid pool with cholestyr-
regulatory responses in bile acid biosynthesis, addi-amine enhanced CYP7A1 and CYP8B1 expression. We
tional mechanisms may exist that affect bile acid output.conclude that input from three negative regulatory
These are exemplified by mutations in the mouse he-pathways controls bile acid synthesis. One is mediated
patic nuclear factor 1, hepatic nuclear factor 4, andby SHP, and two are SHP independent and invoked
pregnane X receptor genes (all of which cause alter-by liver damage and changes in bile acid pool size.
ations in bile acid metabolism [Hayhurst et al., 2001;
Shih et al., 2001; Staudinger et al., 2001; Xie et al., 2001])Introduction
and by regulatory responses mediated by serine/threo-
nine kinases (Fabiani et al., 2001; Gupta et al., 2001),The synthesis of bile acids from cholesterol in the liver
cytokines (Miyake et al., 2000), and members of therequires the coordinated actions of a dozen enzymes
fibroblast growth factor family (Yu et al., 2000). In theselocated in every major compartment of the hepatocyte.
cases, it has proven difficult to distinguish between re-In this pathway, a soluble end product is formed from
ceptor-dependent and receptor-independent regulationcholesterol by the addition of hydroxyl groups and the
due in part to the complexity of the biological system
oxidation of the side chain. The solubility of bile acids
and the large number of genes involved.
facilitates their excretion, and their detergent properties
The current study employs a line of mice deficient in
help to solubilize lipid nutrients in the intestine. SHP to determine the role of this nuclear receptor in
The amount of bile acid synthesized by the liver is the regulation of bile acid synthesis and to search for
closely regulated to prevent overaccumulation of bile alternate regulatory pathways that affect cholesterol
acids on the one hand, and cholesterol on the other. disposal. Characterization of bile acid metabolism in
The regulatory scheme also ensures sufficient bile acids SHP knockout mice reveals that under normal condi-
to solubilize biliary cholesterol and to facilitate lipid di- tions, the inputs of FXR and SHP are sufficient to medi-
gestion and absorption. When bile acids accumulate ate negative feedback regulation of bile acid synthesis.
beyond physiologic levels, a negative feedback mecha- When the organism is stressed, for example by damage
nism is called into play, and synthesis is decreased to the liver, or when the bile acid pool is decreased,
(Russell and Setchell, 1992). Conversely, bile acid syn- alternate pathways of regulation come into play that
thesis is increased when the substrate, cholesterol, ac- lead to changes in bile acid synthesis.
cumulates. Both of these regulatory responses are tran-
scriptional in nature and are mediated by members of Results
the nuclear hormone receptor family acting on two
genes that encode hydroxylase enzymes in the biosyn- Deletion of Shp Gene
thetic pathways (Chawla et al., 2001). Mutation of the SHP gene (Shp) was accomplished by
As summarized in Figure 1, suppression of bile acid replacement of 318 bp of exon 1 with a cassette encod-
ing antibiotic resistance (Figure 2A). Homologous re-
combination in embryonic stem cells, injection into blas-4 Correspondence: mschwarz@tularik.com (M.S.), russell@utsw.
swmed.edu (D.W.R.) tocysts, and transmission of the mutation through the
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results to mean that the replacement mutation produced
a null allele of Shp.
Mice lacking SHP and maintained on standard labora-
tory chow were grossly normal, did not experience un-
timely deaths, and produced expected numbers of male
and female offspring. No abnormalities were detected
in tissue weights when normalized to total body weight.
We were unable to assess whether the absence of SHP
caused an obesity phenotype in mice as it does in hu-
mans (Nishigori et al., 2001) since the mouse mutation
was maintained on a mixed strain background (C57BL/
6-129/OlaHsd), and individual weights of both wild-type
and knockout animals varied extensively.
Figure 1. Regulation of Bile Acid Synthesis by Nuclear Receptors
A scheme depicting the roles of four nuclear receptors in regulating
bile acid synthesis is shown. Green arrows indicate positive regula- Bile Acid Composition
tion while the red brake indicates negative regulation.
The composition of the bile acid pool reflects in large
part the expression of biosynthetic enzymes in the liver.
To determine how loss of SHP affected the types of bile
mouse germ line (Figure 2B) were carried out with stan-
acid present in male knockout mice, total bile acids weredard methods (Hogan et al., 1995). Two aspects of the
extracted from the gut, liver, and gallbladder and theirintroduced mutation were predicted to eliminate Shp
structures determined by gas chromatography-massexpression. First, the loss of106 amino acids encoded
spectrometry (GC-MS). Shp/ mice had markedly ele-by exon 1 should remove required portions of the ligand
vated levels of cholic acid in their bile relative to wild-binding and dimerization domains from the SHP protein.
type mice (Figure 3). The increase in cholic acid wasSecond, the orientation of the inserted neomycin resis-
accompanied by a corresponding decrease in the pri-tance gene was opposite that of Shp and thus should
mary bile acid, -muricholate. Levels of deoxycholicinterfere with transcription from the gene. RNA blotting
acid, a secondary bile acid derived from cholic acid,revealed a Shp transcript of1.1 kb in the livers of wild-
were also elevated in the Shp/ mice, whereas thetype mice and trace amounts of a truncated mRNA of
amounts of five other secondary bile acids were un-0.8 kb in Shp/ mice (Figure 2C). Reverse tran-
changed relative to those in wild-type mice (Figure 3).scriptase PCR and DNA-sequencing experiments indi-
These data provided an early indication that the absencecated that the mRNA transcribed from the mutant allele
of SHP altered the expression of enzymes involved inwas a chimera composed of SHP sequences, anti-sense
bile acid synthesis, in particular that of sterol 12-neomycin resistance sequences, and unknown se-
hydroxylase, which is responsible for the synthesis ofquences that did not contain an extended translational
reading frame (data not shown). We interpreted these cholic acid.
Figure 2. Deletion of Mouse SHP Gene
(A) Schematic representation of the wild-type
SHP gene showing the two exon structure
(Lee et al., 1998), the targeting vector in which
a cassette encoding neomycin resistance re-
places 318 bp of SHP exon 1, and the struc-
ture of the mutant allele arising after homol-
ogous recombination. Arrows below the
neomycin resistance cassette indicate the
direction of transcription from the gene.
(B) Genotype analysis in mice with different
Shp alleles. Genomic DNA was isolated from
animals of the indicated genotype and ampli-
fied via PCR using allele-specific primers
described in Experimental Procedures. Prod-
ucts were separated by agarose gel electro-
phoresis.
(C) Blot analysis of mouse liver SHP mRNA
isolated from wild-type (/), heterozygous
(/), and homozygous knockout (/)
mice. Poly(A) RNA was isolated from ani-
mals (n  6) of the indicated Shp genotype,
and aliquots (2 g) were separated by gel
electrophoresis, transferred to nylon mem-
branes, and hybridized to a radiolabeled SHP cDNA probe representing exon 1 of the gene (SHP, upper panel). After autoradiography, the
filters were stripped of bound radioactivity and reprobed with a radiolabeled cDNA encoding rat cyclophilin (Cyclo, lower panel). The truncated
mRNA detected in the Shp/ sample is composed of portions of SHP exons 1 and 2, sequences from the noncoding strand of the neomycin
resistance gene, and sequences of unknown origin.
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Figure 4. Parameters of Bile Acid and Cholesterol Metabolism
(A) The amount of bile acid present in mice of the indicated geno-
types (n 6–7) was determined by high-pressure liquid chromatog-
raphy. Values graphed in the left panel represent the mean  SEM
and were significantly larger (*, p  0.013) in Shp/ mice. Bile acid
Figure 3. Composition of Bile Acid Pool in Male Wild-Type and
excretion (right panel) was determined after extraction and enzyme
Shp/ Mice
assay. Mutant mice (n  5) excreted significantly more bile acid
Ethanolic extracts of the intestine, liver, and gallbladder of mice of (p  0.010) and thus had higher hepatic synthesis rates than did
the indicated genotypes (n 5) were analyzed by gas chromatogra- wild-type controls (n  5).
phy-mass spectrometry. Amounts of individual bile acids are indi- (B) Cholesterol absorption was measured in 14 animals of the indi-
cated as a percentage of the entire pool. The positions of hydroxyl cated genotype by a dual isotope fecal assay and mean values 
groups on the ring structures and their stereochemistries are indi- SEM plotted as a histogram (left panel). Shp/ mice absorbed 22%
cated in parentheses. The level of cholic acid increased and that of more cholesterol than did wild-type mice; however, the difference
-muricholic acid decreased in Shp/ mice. did not reach statistical significance. Neutral sterol excretion was
significantly lower (*, p  0.0016) in the knockout mice (right panel,
n  5) and thus confirmed the finding of increased absorption.
Bile Acid Pool Size and Synthetic Rate
The total mass of bile acid present in SHP wild-type and
statistical significance in this experiment, increased ab-knockout male mice was determined by high-perfor-
sorption was detected in multiple independent experi-mance liquid chromatography (HPLC). These analyses
ments. Second, the excretion rate of neutral sterols wasrevealed that the bile acid pool in mutant animals was
significantly decreased (p  0.0016) in the mutant mice32% larger than that in normal controls (Figure 4A, left
(Figure 4B, right panel). Inasmuch as increases in cholicpanel). This increase was statistically significant (p 
acid pool size are known to increase intestinal choles-0.013).
terol absorption and decrease sterol excretion (DietschyFecal bile acid excretion rates were measured to de-
and Turley, 2002), these data provided an independenttermine whether the enlarged pool size in the Shp/
confirmation of the experimental outcomes reported formice was due to an increased rate of synthesis. These
the Shp/ mice in Figures 3 and 4A.measurements indicated that the absence of SHP led
No differences were detected in plasma cholesterol,to a 33% increase in fecal bile acid excretion (Figure
triglyceride, or lipoprotein levels between the knockout4A, right panel). Since the mass of bile acid excreted is
and wild-type mice. Even though the absorption of di-directly proportional to the amount synthesized in the
etary cholesterol was enhanced in the Shp/ animals,liver, these data suggested a generalized derepression
there was no decrease in hepatic sterol synthesis (dataof bile acid synthesis in the Shp/ animals.
not shown), presumably because the excess cholesterol
was being converted to bile acids. The excretion of totalCholesterol Absorption and Excretion
fecal lipid was also unchanged in the mutant mice.Changes in bile acid metabolism in the mouse generally
cause corresponding alterations in how the animal han-
dles cholesterol. We determined several parameters of Cholesterol 7-Hydroxylase Expression
The loss of SHP was predicted to lead to derepressionsterol metabolism in Shp/ mice and found genotype-
specific differences in two of them. First, the absorption of the cholesterol 7-hydroxylase gene (Figure 1), and in
agreement with this hypothesis, Shp/mice maintainedof cholesterol in the gut was elevated by 22% in knock-
out male mice relative to wild-type controls (Figure 4B, on normal rodent chow had modestly elevated levels of
CYP7A1 mRNA, protein, and enzyme activity (Figuresleft panel), and although this difference did not reach
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Figure 5. Expression of Cholesterol 7-Hydroxylase
(A) CYP7A1 and cyclophilin mRNA levels in livers (n  9) of wild-
type and Shp/ mice were determined by blot hybridization of
poly(A)-enriched RNA. Densitometric scanning of the resulting au-
toradiogram indicated that the CYP7A1 mRNA was 2- to 3-fold more
abundant in knockout mice. Figure 6. Gene Expression in Wild-Type and Shp/ Mice
(B) Enzyme activity was measured in a gas chromatography-based (A) Aliquots (3 g) of poly(A)-enriched RNA isolated from the liver
assay using hepatic microsomes isolated from animals (n  5) of or small intestine (n  5 mice per genotype) were analyzed by blot
the indicated Shp genotypes. Values in the mutant mice were ap- hybridization with cDNA probes for the indicated mRNAs. A signal
proximately 20%–30% higher than those in the controls. for cyclophilin was used to normalize relative expression levels.
(C) Immunodetection of CYP7A1 protein. Aliquots containing ap- (B) RNA was prepared from pooled livers dissected from wild-type
proximately 150 g of microsomal protein were subjected to immu- and Shp knockout animals (n  5) and converted into cDNA in
noblotting as described in Experimental Procedures. Signals ema- the presence of a deoxynucleoside triphosphate derivatized with a
nating from Shp/ samples were approximately 2-fold stronger as fluorescent dye. Different dyes were used to label the wild-type and
judged by densitometry, while those from a control protein (heavy knockout cDNA probes, which were subsequently hybridized to a
chain binding protein, BIP) were unchanged. microarray containing 400 cDNAs whose encoded proteins are
involved in lipid or carbohydrate metabolism. Genes with the largest-
fold increases in the chip hybridization experiments were then quan-
titated by real-time PCR. GPAT, glycerol phosphate acyltransferase;5A–5C). The increases in mRNA and protein, which were
FAS, fatty acid synthetase.at most 2- to 3-fold (Figure 5), were less than those
observed in mice lacking sterol 27-hydroxylase (Repa
et al., 2000; Rosen et al., 1998), FXR (Sinal et al., 2000), a potent ligand of FXR, a transcriptional activator of the
BSEP gene (Ananthanarayanan et al., 2001). Not all FXRor sterol 12-hydroxylase (J. Li-Hawkins et al., submit-
ted) in which 5- to 7-fold increases in CYP7A1 expres- target genes were altered in their expression patterns,
since levels of the Na-taurocholate cotransportingsion were found. The 2- to 3-fold increase in mRNA
and protein caused an increase of only 20%–30% in polypeptide 2 (Ntcp2, SLC10A1) mRNA were the same
between mice of different Shp genotypes (Figure 6A).measured CYP7A1 enzyme activity, which correlated
with the 33% increase in bile acid synthesis (Figure 4A). The mRNAs specifying other enzymes involved in bile
acid synthesis were unchanged, but levels of the scav-These findings raise the possibility that CYP7A1 activity
is subject to posttranslational regulation. enger receptor SR-B1 mRNA were approximately 3-fold
elevated (Figure 6A).
In a second series of experiments, we assessed howOther Alterations in Gene Expression
To determine how loss of SHP affected the expression SHP loss affected the relative mRNA levels of 400 genes
involved in lipid and carbohydrate metabolism. A cDNAof other genes, we first measured mRNA levels of candi-
date genes involved in bile acid and cholesterol metabo- microarray was probed with differentially labeled cDNA
transcribed from hepatic mRNA of wild-type and Shp/lism by blotting. An increased level of sterol 12-
hydroxylase mRNA was detected in the Shp/ mice mice and the results analyzed according to stringent
criteria. Real-time PCR was then used to confirm the(Figure 6A), which is consistent with the elevation in
cholic acid found in the bile acid pool (Figure 3). This results of the chip hybridization assay. Representative
mRNAs whose expression was found to be increasedresult was expected, as the expression of the Cyp8b1
gene, which encodes sterol 12-hydroxylase, is nega- using both assays are listed in Figure 6B. In agreement
with previous findings indicating that SHP inhibits sev-tively regulated by SHP (Castillo-Olivares and Gil, 2000,
2001). The bile salt export protein (BSEP, ABCB11) eral different members of the nuclear receptor family
(Seol et al., 1996), a majority of mRNAs whose expres-mRNA was also elevated in the mutant mice (Figure 6A),
presumably due to the increase in cholic acid, which is sion changed in the knockout mice increased in amount.
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Only a few mRNAs were less abundant, and in these
cases, the decreases were modest (50%, data not
shown). Genes increased in expression encoded ABC
transporters (ABCA1, ABCG5, ABCG8, and ABCG1), a
cholesterol esterification enzyme (ACAT1), and other
products involved in fat metabolism. The levels of
mRNAs found to be elevated in the RNA blotting experi-
ments (Figure 6A) were also increased when measured
by real-time reverse transcriptase PCR. Whether these
changes in gene expression are attributable directly to
the loss of the negative regulator, SHP, or whether they
are secondary to the widespread changes in cholesterol
and bile acid metabolism remains to be determined.
Regulation by FXR Agonists
A key prediction regarding the regulatory role of SHP
in bile acid metabolism concerns the response of the
knockout animals to excess bile acids. If, as proposed,
SHP is responsible for the inhibition of cholesterol
7-hydroxylase and sterol 12-hydroxylase gene tran-
scription (Figure 1), then these genes should no longer
be repressed in response to dietary bile acids in Shp/
mice. To test this hypothesis, wild-type and mutant mice
(n 4–6) were fed diets supplemented with 0.25% cholic
acid for 5 days, and hepatic mRNA levels were measured
by real-time reverse transcriptase PCR. In the same
experiment, separate groups of animals were treated
by gavage with a potent agonist of FXR, GW4064 (Good-
win et al., 2000), at 100 mg/kg body weight. We antici-
pated that the results obtained with this compound
would mimic those obtained with cholic acid feeding.
As expected, dietary cholic acid decreased CYP7A1
and CYP8B1 mRNA levels in wild-type mice, as did
GW4064 (Figure 7A, left panel). Unexpectedly, bile acid
feeding decreased the levels of the hydroxylase mRNAs
Figure 7. Responses to Dietary Bile Acids, Cholestyramine, andin Shp/ mice, but treatment with the FXR agonist did
FXR Agonist GW4064
not (Figure 7A, right panel). In some experiments, diets
(A) Mice of different Shp genotypes (n  4–6 each) were fed the
supplemented with 0.25% or 0.5% cholic acid were le- indicated diets (normal versus chow supplemented with 0.25%
thal to Shp/ mice, but not to wild-type mice. These [w/w] cholic acid) or gavaged with the FXR agonist GW4064 (100
observations prompted us to assess liver damage by mg/kg body weight, q.d.) for 5 days. Livers were dissected, total RNA
prepared and pooled, and cholesterol 7-hydroxylase (CYP7A1) andmeasuring the levels of hepatic enzymes in the plasma.
sterol 12-hydroxylase (CYP8B1) mRNA levels determined by real-As shown by the data in the lower panels of Figure
time reverse transcriptase PCR (upper panel) in individual animals.7A, neither cholic acid feeding nor GW4064 treatment
The numbers shown are the averages of triplicate determinations
elevated plasma levels of hepatic aspartate aminotrans- for each mRNA. Hepatic enzyme levels (AST, aspartate aminotrans-
ferase (AST) or alanine aminotransferase (ALT) in wild- ferase; ALT, alanine aminotransferase) were determined in pooled
type mice; however, bile acid, but not GW4064, caused plasmas from the same groups of mice (lower panel).
(B) Animals were fed chow diet supplemented with nothing oran enormous elevation in the circulating levels of these
cholestyramine (2%, w/w) for 5 days. CYP7A1 and CYP8B1 mRNAenzymes in Shp/ mice. Together these results sug-
levels were quantitated as described in (A).gested that the downregulation of cholesterol 7-
hydroxylase and sterol 12-hydroxylase mRNAs by bile
acid in the knockout mice was a consequence of hepato- Discussion
toxicity.
The effect of reducing the bile acid pool on hydroxy- The current studies test the hypothesis that the nuclear
receptor SHP is responsible in vivo for negative feed-lase gene expression was assessed by feeding chole-
styramine, a polyanionic polymer that binds bile acids back regulation exerted by bile acids on their synthesis.
The data show that mice lacking SHP increase the syn-in the small intestine and prevents their return to the
liver. Dietary cholestyramine increased the levels of cho- thesis and accumulation of bile acids and produce more
cholic acid than their wild-type counterparts. These in-lesterol 7-hydroxylase mRNA in normal mice (Figure
7B). An identical response was observed in Shp/ mice creases are caused by a loss of regulation of cholesterol
7-hydroxylase, the rate-limiting enzyme of bile acidexcept that the levels of CYP7A1 mRNA were higher
than those reached in the wild-type mice (Figure 7B). synthesis, and of sterol 12-hydroxylase, which synthe-
sizes cholic acid, a potent agonist of FXR. When levelsHepatic enzymes in the plasma were not elevated in the
cholestyramine-fed mice (data not shown). of bile acid in Shp knockout mice are raised further by
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dietary manipulation, cholestasis results, and the syn- since the expression of an enzyme in the alternate path-
way of bile acid synthesis (the CYP7B1 oxysterolthesis of these enzymes declines. Conversely, when bile
acid levels are decreased in Shp/ mice by cholestyr- 7-hydroxylase) is also decreased in this experiment,
whereas mRNAs encoding CPF, OATP2, and stearoylamine feeding, synthesis increases. We conclude from
these results that SHP is responsible for maintaining CoA-desaturase are unchanged. Mice fed lithocholic
acid, a potent cholestatic agent and ligand for the nu-bile acid homeostasis under normal conditions and that
at least two SHP-independent regulatory pathways exist clear receptor PXR (Xie et al., 2001), repress CYP7A1
expression via a PXR-dependent pathway (Staudingerto inhibit bile acid synthesis.
A central role for SHP in regulating bile acid metabo- et al., 2001). We believe this regulatory response is dif-
ferent from that observed here, as the expression oflism was first proposed from results obtained in cultured
cells (Goodwin et al., 2000; Lu et al., 2000). These studies other lithocholic acid and PXR responsive genes, includ-
ing CYP3A and OATP2, is unchanged in Shp/ mice,revealed that expression of SHP inhibited transcription
from a cholesterol 7-hydroxylase reporter gene, and even in those fed cholic acid.
The synthesis of bile acids in the mouse is thus con-they traced the mechanism to the formation of an inhibi-
tory complex between SHP and a second nuclear recep- trolled by at least four negative regulatory inputs. One
is mediated by the nuclear hormone receptor SHP andtor (CPF/LRH/FTF/NR5A2) required for expression of
CYP7A1 (Nitta et al., 1999). By acting in this manner, responds to bile acid pool size and composition and is
the major regulatory pathway under normal conditions.SHP fulfilled an antireceptor hypothesis put forth when
the molecule was isolated (Seol et al., 1996) and empha- A second is independent of SHP and is inactivated in
response to reduction of the bile acid pool. A third inhibi-sized a close functional and structural relationship with
tory pathway comes into play when the liver is damageda second inhibitory receptor, DAX (Goodfellow and
and also does not require SHP. Input from the latterCamerino, 2001). Expression of the mouse SHP gene
pathway decreases the steady-state levels of thewas further shown to be responsive to FXR in vivo and
CYP7A1 and CYP8B1 mRNAs, which suggests a tran-to FXR and CPF in vitro (Goodwin et al., 2000; Lee et
scriptional mechanism of action; however, experimentsal., 1999; Lu et al., 2000), thus completing a regulatory
to rule out more complex mechanisms have not yetloop for the control of bile acid synthesis (Figure 1).
been performed. We do not know the identities of theThe in vivo results presented here confirm and extend
transcription factors that participate in the SHP-inde-these observations. As predicted from the in vitro data,
pendent regulatory pathways. These may include nu-loss of SHP causes increased expression of cholesterol
clear receptors, such as FXR (which is fully functional7-hydroxylase, and a second CPF target gene, sterol
in the Shp/ mice and is also bathed in excess amounts12-hydroxylase (Castillo-Olivares and Gil, 2000, 2001).
of cholic acid in these animals [Figure 3]), or other tran-In the absence of SHP, CPF presumably has unopposed
scription factors. A fourth negative regulatory pathwayaccess to binding sites in the Cyp7a1 and Cyp8b1 pro-
is mediated by the receptor PXR and is induced bymoters, resulting in enhanced transcription from these
lithocholic acid-mediated cholestasis (Staudinger et al.,target genes. Surprisingly, the levels of CYP7A1 and
2001). Future experiments in mice lacking more thanCYP8B1 mRNAs in the Shp/ mice were only 2-fold
one nuclear receptor may reveal the identities of otherhigher than those in wild-type mice (Figures 5 and 6).
transcription factors that regulate bile acid synthesis.These elevations were less than the 5- to 7-fold in-
In addition to mRNAs encoding bile acid biosyntheticcreases observed in animals with reduced bile acid pool
enzymes, the expression of numerous other mRNAs issizes (e.g., sterol 27-hydroxylase-deficient mice [Repa
increased in Shp/ mice (Figure 6). Enhanced expres-et al., 2000]) or with an altered composition of the bile
sion may occur by unregulated CPF activity, as is theacid pool (e.g., sterol 12-hydroxylase-deficient mice
case for the CYP7A1 and CYP8B1 hydroxylases, or via[J. Li-Hawkins et al., submitted]). The less than expected
FXR due to the altered bile acid pool size or composition,increases in hydroxylase mRNA levels of Shp/ mice
as is the case with BSEP. Whether other nuclear recep-suggest that another negative regulatory mechanism
tors are involved in the expression of these genes, asexists to keep these enzymes in check. This SHP-inde-
would be predicted from in vitro studies, remains topendent pathway must in some manner sense the bile
be determined, as does the role of SHP in peripheralacid pool given the results in the hydroxylase-deficient
tissues.animals and the fact that reducing the bile acid pool in
Shp/ mice by feeding cholestyramine raises CYP7A1
Experimental Procedures
and CYP8B1 mRNA levels (Figure 7B).
Evidence for a third negative regulatory pathway influ- Animals and Diets
Deltagen, Inc. generated Shp/ mice under contract using standardencing Cyp7a1 and Cyp8b1 expression is obtained in
gene-targeting methods (Hogan et al., 1995). To disrupt the ShpShp/ mice fed bile acids. In this situation, excess bile
locus, a 318 bp fragment corresponding to a segment of exon 1 (Leeacids cause liver damage, as judged by the release of
et al., 1998) was replaced by a phosphoglycerate kinase promoter-
hepatic enzymes into the serum, and they decrease hy- driven geneticin/neomycin resistance cassette in a targeting vector,
droxylase gene expression (Figure 7A). The reduction and this DNA was linearized and electroporated into embryonic
stem cells derived from the 129/OlaHsd strain. Positive (geneticin)appears to be dependent on liver impairment and inde-
selection and screening produced multiple cell lines that harboredpendent of FXR, as treatment with an FXR agonist does
the desired mutation. Cells from several different lines were injectednot cause cholestasis and does not decrease CYP7A1 or
into recipient C57BL/6J blastocysts to produce chimeras that trans-
CYP8B1 mRNA levels. We speculate that this response mitted the mutation through the germ line. One of the transmitting
represents a specific protective mechanism designed high-percentage male chimeras was out crossed to C57BL/6J fe-
males to produce F1 heterozygotes, which were intercrossed toto eliminate bile acid synthesis in the face of liver injury,
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produce F2 wild-type, heterozygous, and homozygous mice in the using five matrix-assisted calibration standards containing 3, 10,
30, 100, or 300 ng of 7-hydroxycholesterol and 30 ng of 7-expected Mendelian ratios. Genotyping was accomplished by PCR
using primer pairs specific for the wild-type Shp allele (ATGAGCTC hydroxycholesterol.
CGGCCAGTCAGGGGTCT; TTCTTAAGTATACTGGGCACCGGAG) or
mutant allele (ATGAGCTCCGGCCAGTCAGGGGTCT; GGGGATCGA Acknowledgments
TCCGTCCTGTAAGTCT).
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